• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非培养方法诊断类鼻疽的诊断准确性:一项系统评价和荟萃分析

Diagnostic accuracy of non-culture methods for the diagnosis of melioidosis: a systematic review and meta-analysis.

作者信息

Chen Chuizhe, Fang Junde, Li Xuemiao, Rajaofera Mamy Jayne Nelly, Zhang Nan, Zhang Yuanyuan, Xia Qianfeng

机构信息

NHC Key Laboratory of Tropical Disease Control, School of Tropical Medicine, Hainan Medical University, Haikou, 571199, Hainan, China.

Department of Cardiology, The First Affiliated Hospital, Hainan Medical University, Haikou, 570102, China.

出版信息

BMC Infect Dis. 2025 Jul 1;25(1):851. doi: 10.1186/s12879-025-11214-9.

DOI:10.1186/s12879-025-11214-9
PMID:40596932
Abstract

BACKGROUND

The accuracy of laboratory diagnostic tests for the rapid diagnosis of melioidosis and their potential to replace culture tests as the gold standard remain controversial. This study aims to comprehensively evaluate the accuracy of all rapid diagnostic tests.

RESEARCH DESIGN AND METHODS

A systematic search of PubMed, Embase, SCIE, the Cochrane Library, and Scopus databases was conducted up to July 12, 2024, to include diagnostic tests for melioidosis with culture as the gold standard. The diagnostic accuracy of all testing methods was evaluated using a bivariate mixed-effects model and an ANOVA model.

RESULTS

A total of 36 studies, comprising 21,289 tests, were included in this systematic review and meta-analysis. Using the bivariate mixed-effects model, the pooled sensitivity of indirect ELISA was 0.86 [95% CI (0.80-0.90)] and the pooled specificity was 0.85 [95% CI (0.80-0.89)]. For IHA with a positive threshold of 1:160, the pooled sensitivity was 0.60 [95% CI (0.46-0.72)] and the pooled specificity was 0.70 [95% CI (0.58-0.79)]. The pooled sensitivity of LFI targeting CPS was 0.52 [95% CI (0.33-0.70)] and the pooled specificity was 0.96 [95% CI (0.93-0.98)]. For IFA targeting polyclonal antibody, the pooled sensitivity was 0.60 [95% CI (0.44-0.75)] and the pooled specificity was 0.99 [95% CI (0.97-1.00)]. The pooled sensitivity of RT-PCR targeting T3SS was 0.72 [95% CI (0.41-0.91)] and the pooled specificity was 1.00 [95% CI (0.97-0.99)]. Other testing methods could not be meta-analyzed due to insufficient study numbers. The ANOVA model for network meta-analysis of the five most common testing methods showed that IFA targeting polyclonal antibody had the best advantage with a Superiority index of 6.86. In contrast, IHA with a positive threshold of 1:160 had the poorest advantage with a Superiority index of 0.19.

CONCLUSION

While rapid diagnostic methods for B. pseudomallei infection exist, bacterial culture remains the gold standard. In resource-limited settings, we recommend antigen-targeted sandwich ELISA for acute/early-stage melioidosis and IgG-based indirect ELISA for late acute or chronic cases. In high-resource settings, RT-PCR targeting the T3SS is recommended as an adjunct diagnostic modality. Strengthening training for clinicians and laboratory personnel is essential to ensure accurate application and interpretation.

TRIAL REGISTRATION

CRD42024569385.

摘要

背景

用于类鼻疽快速诊断的实验室诊断测试的准确性以及它们取代培养测试作为金标准的潜力仍存在争议。本研究旨在全面评估所有快速诊断测试的准确性。

研究设计与方法

截至2024年7月12日,对PubMed、Embase、SCIE、Cochrane图书馆和Scopus数据库进行了系统检索,纳入以培养作为金标准的类鼻疽诊断测试。使用双变量混合效应模型和方差分析模型评估所有测试方法的诊断准确性。

结果

本系统评价和荟萃分析共纳入36项研究,包括21289次测试。使用双变量混合效应模型,间接ELISA的合并敏感性为0.86 [95%可信区间(0.80 - 0.90)],合并特异性为0.85 [95%可信区间(0.80 - 0.89)]。对于阳性阈值为1:160的间接血凝试验(IHA),合并敏感性为0.60 [95%可信区间(0.46 - 0.72)],合并特异性为0.70 [95%可信区间(0.58 - 0.79)]。靶向荚膜多糖的侧向流动免疫分析(LFI)的合并敏感性为0.52 [95%可信区间(0.33 - 0.70)],合并特异性为0.96 [95%可信区间(0.93 - 0.98)]。对于靶向多克隆抗体的间接荧光抗体试验(IFA),合并敏感性为0.60 [95%可信区间(0.44 - 0.75)],合并特异性为0.99 [95%可信区间(0.97 - 1.00)]。靶向三型分泌系统(T3SS)的逆转录聚合酶链反应(RT-PCR)的合并敏感性为0.72 [95%可信区间(0.41 - 0.91)],合并特异性为1.00 [95%可信区间(0.97 - 0.99)]。由于研究数量不足,其他测试方法无法进行荟萃分析。对五种最常用测试方法进行网络荟萃分析的方差分析模型显示,靶向多克隆抗体的IFA优势最佳,优势指数为6.86。相比之下,阳性阈值为1:160的IHA优势最差,优势指数为0.19。

结论

虽然存在针对假鼻疽伯克霍尔德菌感染的快速诊断方法,但细菌培养仍是金标准。在资源有限的环境中,我们建议针对急性/早期类鼻疽使用抗原靶向夹心ELISA,针对晚期急性或慢性病例使用基于IgG的间接ELISA。在资源丰富的环境中,建议将靶向T3SS的RT-PCR作为辅助诊断方法。加强对临床医生和实验室人员的培训对于确保准确应用和解释至关重要。

试验注册

CRD42024569385。

相似文献

1
Diagnostic accuracy of non-culture methods for the diagnosis of melioidosis: a systematic review and meta-analysis.非培养方法诊断类鼻疽的诊断准确性:一项系统评价和荟萃分析
BMC Infect Dis. 2025 Jul 1;25(1):851. doi: 10.1186/s12879-025-11214-9.
2
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.用于检测对二线抗结核药物耐药性的GenoType(®) MTBDRsl检测法的诊断准确性。
Cochrane Database Syst Rev. 2014 Oct 29(10):CD010705. doi: 10.1002/14651858.CD010705.pub2.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
7
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
8
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
9
Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients.肾移植和肾胰联合移植受者中BK多瘤病毒相关性肾病的血清和尿液核酸筛查试验
Cochrane Database Syst Rev. 2024 Nov 28;11(11):CD014839. doi: 10.1002/14651858.CD014839.pub2.
10
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.

本文引用的文献

1
Melioidosis with venous thrombosis and cellulitis in the left lower limb: a case report.伴有左下肢静脉血栓形成和蜂窝织炎的类鼻疽:病例报告
J Med Case Rep. 2025 Apr 9;19(1):168. doi: 10.1186/s13256-025-05190-6.
2
Comparison evaluation of bacterial DNA extraction methods for improved molecular diagnostic accuracy of sepsis-causing pathogens in clinical whole blood samples.用于提高临床全血样本中引起败血症病原体分子诊断准确性的细菌DNA提取方法的比较评估。
Sci Rep. 2025 Feb 4;15(1):4167. doi: 10.1038/s41598-025-87225-y.
3
Optimization and prospective evaluation of sensitive real-time PCR assays with an internal control for the diagnosis of melioidosis in Thailand.
泰国应用内对照物优化和前瞻性评估敏感实时 PCR 检测方法用于诊断类鼻疽。
Microbiol Spectr. 2023 Dec 12;11(6):e0103923. doi: 10.1128/spectrum.01039-23. Epub 2023 Oct 11.
4
Sensitivity and specificity of DPP® Fever Panel II Asia in the diagnosis of malaria, dengue and melioidosis.DPP® Fever Panel II Asia 对疟疾、登革热和类鼻疽的诊断敏感性和特异性。
J Med Microbiol. 2022 Aug;71(8). doi: 10.1099/jmm.0.001584.
5
Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis.评估用于诊断类鼻疽病的抗原检测和抗体检测诊断试验组合。
PLoS Negl Trop Dis. 2021 Nov 2;15(11):e0009840. doi: 10.1371/journal.pntd.0009840. eCollection 2021 Nov.
6
Clinico-microbiological description and evaluation of rapid lateral flow immunoassay and PCR for detection of Burkholderia pseudomallei from patients hospitalized with sepsis and pneumonia: A twenty-one months study from Odisha, India.从印度奥里萨邦一项为期 21 个月的研究:对快速侧向流动免疫测定和 PCR 检测败血症和肺炎住院患者中类鼻疽伯克霍尔德菌的临床微生物学描述和评估。
Acta Trop. 2021 Sep;221:105994. doi: 10.1016/j.actatropica.2021.105994. Epub 2021 Jun 9.
7
Development and validation of TaqMan real-time PCR for the detection of Burkholderia pseudomallei isolates from Malaysia.用于检测马来西亚类鼻疽伯克霍尔德菌分离株的TaqMan实时荧光定量PCR的开发与验证
Trop Biomed. 2019 Jun 1;36(2):379-389.
8
Systematic review and meta-analysis of diagnostic tests for diagnosis of melioidosis.系统性综述和荟萃分析用于诊断类鼻疽的诊断试验。
Acta Trop. 2021 Feb;214:105784. doi: 10.1016/j.actatropica.2020.105784. Epub 2020 Dec 6.
9
Human Melioidosis.类鼻疽病。
Clin Microbiol Rev. 2020 Mar 11;33(2). doi: 10.1128/CMR.00006-19. Print 2020 Mar 18.
10
Detection among Hospitalized Patients, Sarawak.在沙捞越住院患者中进行检测。
Am J Trop Med Hyg. 2020 Feb;102(2):388-391. doi: 10.4269/ajtmh.19-0625.